New York State Common Retirement Fund
PMVP icon

New York State Common Retirement Fund’s PMV Pharmaceuticals PMVP Stock Holding History

New York State Common Retirement Fund’s Portfolio PMVP Stock Details PMVP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-341
Closed -$552 – 3306
2024
Q2 		$552 Sell
341
-9,820
-97% -$17.7K ﹤0.01% 3330
2024
Q1 		$17.3K Sell
10,161
-62
-0.6% -$116 ﹤0.01% 3154
2023
Q4 		$31.7K Sell
10,223
-83
-0.8% -$220 ﹤0.01% 3094
2023
Q3 		$63.3K Buy
10,306
+137
+1% +$942 ﹤0.01% 2933
2023
Q2 		$63.7K Sell
10,169
-49
-0.5% -$257 ﹤0.01% 3081
2023
Q1 		$48.7K Sell
10,218
-16,700
-62% -$118K ﹤0.01% 2992
2022
Q4 		$234K Sell
26,918
-14
-0.1% -$149 ﹤0.01% 2669
2022
Q3 		$320K Buy
26,932
+151
+0.6% +$2.18K ﹤0.01% 2562
2022
Q2 		$382K Buy
26,781
+7,848
+41% +$114K ﹤0.01% 2481
2022
Q1 		$394K Buy
18,933
+25
+0.1% +$441 ﹤0.01% 2503
2021
Q4 		$437K Sell
18,908
-65
-0.3% -$1.57K ﹤0.01% 2504
2021
Q3 		$565K Sell
18,973
-3,644
-16% -$116K ﹤0.01% 2394
2021
Q2 		$773K Buy
22,617
+9,917
+78% +$331K ﹤0.01% 2350
2021
Q1 		$418K Buy
12,700
+2,100
+20% +$82.8K ﹤0.01% 2533
2020
Q4 		$652K Buy
+10,600
New +$416K ﹤0.01% 2221

Other funds holding PMVP

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
EC
Euclidean Capital New York $392M AUM 31.85% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

New York State Common Retirement Fund's PMVP Position: Q3 2024 in Review

New York State Common Retirement Fund sold out of PMV Pharmaceuticals (PMVP) in Q3 2024, closing a stake of 341 shares — an estimated $552 sold.

New York State Common Retirement Fund first reported a position in PMVP in Q4 2020 and held it in 15 quarters. The position peaked at $773K in Q2 2021. 74 funds tracked by Wall St. Rank hold PMVP as of Q3 2024.

  • New York State Common Retirement Fund reported no remaining PMV Pharmaceuticals position as of Q3 2024 after selling out during the quarter.
  • New York State Common Retirement Fund sold 341 PMV Pharmaceuticals shares in Q3 2024, an estimated $552.
  • New York State Common Retirement Fund first reported a position in PMV Pharmaceuticals in Q4 2020 and held it in 15 quarters.
  • New York State Common Retirement Fund's PMV Pharmaceuticals position peaked at $773K in Q2 2021.
  • 74 funds tracked by Wall St. Rank held PMV Pharmaceuticals as of Q3 2024.

Based on New York State Common Retirement Fund's 13F filing for Q3 2024, filed 28 Oct 2024.